Over 10,000 results
8-K
EX-99.1
ANIX
Anixa Biosciences Inc
17 Apr 23
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
1:45pm
and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
Immune responses were observed at all dose levels
SAN JOSE, Calif … that Cleveland Clinic presented the most up-to-date data from the Phase 1 Trial of its breast cancer vaccine. The data presented showed
8-K
EX-99.2
AVXT
Avax Technologies Inc
26 Jul 00
Current report
12:00am
the presentation of preclinical data on its AC Vaccine-TM- technology,
an autologous cell cancer vaccine, at the 91st Annual Meeting of the American …
Association for Cancer Research (AACR). The presentation outlined findings in a
mouse model of breast cancer, indicating that vaccination with AVAX's AC
40FR12B
EX-99.13
IMVIQ
IMV Inc.
1 May 18
Initial registration of securities (Canada)
4:18pm
company that develops products based on its proprietary vaccine enhancement platform with a primary focus on T cell activating therapies for cancer … and enables the Corporation to pursue vaccine candidates in cancer, infectious diseases and other applications.
The DepoVax™ platform is being used
8-K
EX-99.1
CEGE
Cell Genesys Inc
15 Nov 05
Cell Genesys Announces Favorable 2-YEAR Survival Data from Phase 2 Clinical Trial of Gvax®vaccine for Pancreatic Cancer
12:00am
OF
GVAX®VACCINE FOR PANCREATIC CANCER
Vaccine Administered Following Pancreatic Cancer Surgery and Adjuvant Therapy
SOUTH SAN FRANCISCO, CA, November 15 … , 2005 — Cell Genesys, Inc. (Nasdaq: CEGE) today announced interim findings from a Phase 2 clinical trial of GVAX® vaccine for pancreatic cancer in 60
10-12G/A
EX-99.2
o80tldedj 2hfq
23 Jul 20
Registration of securities (amended)
5:08pm
8-K
b3uhryb
9 Dec 97
Current report
12:00am
8-K
EX-99.1
xyqqh8w8jt78v sez74
28 Sep 05
Advaxis’ Listeria Cancer vaccine results in complete regression of rapidly growing breast tumors
12:00am
8-K
EX-99.1
1hw0a4o94i5typg645d
26 Feb 14
Other Events
12:00am
8-K
EX-99.1
qaam3e d4ipzq1wjah6t
28 Sep 04
Other Events
12:00am
8-K
EX-99.1
z6x63 2i0crr5t
7 Dec 23
Regulation FD Disclosure
6:01am
8-K
EX-99.1
qm8jd2fnc
21 Apr 11
Adamis Completes Acquisition of a Technology for a Potential Universal Cancer Vaccine
12:00am
8-K
EX-99.2
2ps7r19hajcp
10 Sep 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
dv2fvj5
16 Dec 13
Positive Phase 2 Results from Agenus’ Brain Cancer Vaccine Published in Neuro-Oncology
12:00am
8-K
EX-99.1
ow6duw0
1 Jun 11
Biovest Announces that BiovaxID® Personalized Cancer
12:00am
40FR12B
EX-99.27
37lkzdcuwa18
1 May 18
Initial registration of securities (Canada)
4:18pm
8-K
EX-99.1
tjhedvp6yxagek5
2 Oct 01
Other events
12:00am
8-K
EX-99.5
acrrmob4
19 Feb 98
Current report
12:00am
8-K
EX-99.1
yicc6z
27 Jul 04
Cell Genesys Reports Second Quarter Financial Results
12:00am